Simple jQuery Dropdowns

Browsing by Author Thanyanan Reungwetwattana

Jump to: 0-9 A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
or enter first few letters:  
Showing results 1 to 11 of 11
Issue DateTitleAuthor(s)
2016ALK-rearranged pulmonary adenocarcinoma in Thai Patients: From diagnosis to treatment efficacyPimpin Incharoen; Thanyanan Reungwetwattana; Sakditad Saowapa; Kaettipong Kamprerasart; Duangjai Pangpunyakulchai; Lalida Arsa; Artit Jinawath; Mahidol University. Faculty of Medicine Ramathibodi Hospital. Department of Pathology
22-Apr-2011Chemotherapy for non-small-cell lung carcinoma: From a blanket approach to individual therapyThanyanan Reungwetwattana; Matthew J. Eadens; Julian R. Molina; Mahidol University; Mayo Medical School
20-Nov-2018CNS response to osimertinib versus standard epidermal growth factor receptor tyrosine kinase inhibitors in patients with untreated EGFR-mutated advanced non-small-cell lung cancerThanyanan Reungwetwattana; Kazuhiko Nakagawa; Byoung Chul Cho; Manuel Cobo; Eun Kyung Cho; Alessandro Bertolini; Sabine Bohnet; Caicun Zhou; Ki Hyeong Lee; Naoyuki Nogami; Isamu Okamoto; Natasha Leighl; Rachel Hodge; Astrid McKeown; Andrew P. Brown; Yuri Rukazenkov; Suresh S. Ramalingam; Johan Vansteenkiste; Yonsei Cancer Center; Chungbuk National University Hospital; Gachon University; Tongji University; KU Leuven– University Hospital Leuven; Faculty of Medicine, Ramathibodi Hospital, Mahidol University; Universitätsklinikum Schleswig-Holstein Campus Lübeck; National Hospital Organization, Japan; Hospital Regional Universitario Carlos Haya; Kyushu University; Ontario Cancer Institute University of Toronto; AstraZeneca; Emory University School of Medicine; Kindai University; Hospital of Sondrio
1-Jan-2011Current and emerging therapies in peripheral T-cell lymphoma: Focus on pralatrexateThanyanan Reungwetwattana; Sylvia Jaramillo; Julian R. Molina; Mayo Medical School; Mahidol University
1-Jan-2018Determination of irinotecan, SN-38 and SN-38 glucuronide using HPLC/MS/MS: Application in a clinical pharmacokinetic and personalized medicine in colorectal cancer patientsChalirmporn Atasilp; Pichai Chansriwong; Ekapob Sirachainan; Thanyanan Reungwetwattana; Apichaya Puangpetch; Santirhat Prommas; Suwannee Sirilerttrakul; Budsaba Rerkarmnuaychoke; Sansanee Wongwaisayawan; Chonlaphat Sukasem; Faculty of Medicine, Ramathibodi Hospital, Mahidol University
1-Jan-2015MET exon 14 deletion (METex14): Finally, a frequent-enough actionable oncogenic driver mutation in non-small cell lung cancer to lead MET inhibitors out of "40 years of wilderness" and into a clear path of regulatory approvalThanyanan Reungwetwattana; Sai Hong Ignatius Ou; Mahidol University; UCI School of Medicine
1-Jul-2012Oncogenic pathways, molecularly targeted therapies, and highlighted clinical trials in non-small-cell lung cancer (NSCLC)Thanyanan Reungwetwattana; Saravut J. Weroha; Julian R. Molina; Mahidol University; Mayo Clinic
1-Jan-2015A phase i study of the histone deacetylase (HDAC) inhibitor entinostat, in combination with sorafenib in patients with advanced solid tumorsNuttapong Ngamphaiboon; Grace K. Dy; Wen Wee Ma; Yujie Zhao; Thanyanan Reungwetwattana; Dawn Depaolo; Yi Ding; William Brady; Gerald Fetterly; Alex A. Adjei; Roswell Park Cancer Institute; Mahidol University
20-Jan-2018Phase II study of BGJ398 in patients with FGFR-Altered advanced cholangiocarcinomaMilind Javle; Maeve Lowery; Rachna T. Shroff; Karl Heinz Weiss; Christoph Springfeld; Mitesh J. Borad; Ramesh K. Ramanathan; Lipika Goyal; Saeed Sadeghi; Teresa Macarulla; Anthony El-Khoueiry; Robin Kate Kelley; Ivan Borbath; Su Pin Choo; Do Youn Oh; Philip A. Philip; Li Tzong Chen; Thanyanan Reungwetwattana; Eric Van Cutsem; Kun Huei Yeh; Kristen Ciombor; Richard S. Finn; Anuradha Patel; Suman Sen; Dale Porter; Randi Isaacs; Andrew X. Zhu; Ghassan K. Abou-Alfa; Tanios Bekaii-Saab; National Cheng Kung University Hospital; Barbara Ann Karmanos Cancer Institute; National Cancer Centre, Singapore; KU Leuven– University Hospital Leuven; UCSF Helen Diller Family Comprehensive Cancer Center; Mayo Clinic Scottsdale-Phoenix, Arizona; National Taiwan University College of Medicine; Faculty of Medicine, Ramathibodi Hospital, Mahidol University; Keck School of Medicine of USC; University of Texas MD Anderson Cancer Center; Seoul National University; Cliniques Universitaires Saint-Luc, Brussels; Hospital Universitari Vall d'Hebron; Memorial Sloan-Kettering Cancer Center; David Geffen School of Medicine at UCLA; Ohio State University; Universitätsklinikum Heidelberg; Massachusetts General Hospital Cancer Center; Novartis Pharmaceuticals Corporation
1-May-2018Progress in the Management of Malignant Pleural Mesothelioma in 2017Amanda J. McCambridge; Andrea Napolitano; Aaron S. Mansfield; Dean A. Fennell; Yoshitaka Sekido; Anna K. Nowak; Thanyanan Reungwetwattana; Weimin Mao; Harvey I. Pass; Michele Carbone; Haining Yang; Tobias Peikert; Zhejiang Cancer Hospital; University of Leicester; Università degli Studi di Roma La Sapienza; NYU Langone Medical Center; University of Western Australia; Aichi Cancer Center Hospital and Research Institute; Faculty of Medicine, Ramathibodi Hospital, Mahidol University; University of Hawaii at Manoa; Mayo Clinic; Zhejiang Key Laboratory of Diagnosis and Treatment Technology of Thoracic Oncology
1-Jan-2017The race to target MET exon 14 skipping alterations in non-small cell lung cancer: The Why, the How, the Who, the Unknown, and the InevitableThanyanan Reungwetwattana; Ying Liang; Viola Zhu; Sai Hong Ignatius Ou; Mahidol University; Sun Yat-Sen University Cancer Center; VA Medical Center; UCI Medical Center